Form 4: Opaleye Management Inc. Reports Changes in Beneficial Ownership of Protara Therapeutics, Inc. (TARA)

Opaleye Management Inc. reports the purchase and disposal of Protara Therapeutics, Inc. shares through a managed account.

Summary

• Opaleye Management Inc., a 10% owner of Protara Therapeutics, Inc. (TARA), filed a Form 4 detailing changes in beneficial ownership.
• On May 30, 2024, Opaleye disposed of 9,230 shares of common stock at a weighted average price of $2.9375 per share, with prices ranging from $2.90 to $2.98.
• On May 31, 2024, Opaleye disposed of 5,824 shares of common stock at a weighted average price of $2.9009 per share, with prices ranging from $2.9007 to $2.9011.
• Following these transactions, Opaleye's managed account beneficially owns 108,696 shares of Protara Therapeutics, Inc.
• These transactions were executed through a separately managed account, with Opaleye acting as the portfolio manager.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about changes in ownership.

Industry Context

Form 4 filings are standard practice for individuals or entities holding more than 10% of a company's shares, providing transparency into their trading activities. This filing indicates changes in Opaleye Management's position in Protara Therapeutics.

Stakeholder Impact

• Shareholders may be interested in the trading activity of major shareholders like Opaleye Management Inc.

Key Dates